Fundz

Azora Therapeutics, Inc. reported raising $7.73 Million in an initial SEC Form D filing, from an offering of $8.36 Million

RECENTLY ACQUIREDJun 14, 2021$7.7M of $8.4M raised

Amount Raised

$7.73 Million

$7.73 Million sold, per SEC Form D (first sale Jun 14, 2021)

Round Type

Venture

EncinoHealthcare

Quick answer

Azora Therapeutics raised $7.73 Million in a funding round, dated June 14, 2021. Azora Therapeutics is based in Encino, California, United States.

How much did Azora Therapeutics raise?
Azora Therapeutics raised $7.73 Million in a funding round on June 14, 2021.
What does Azora Therapeutics do?
Azora is clinical stage pharmaceutical company developing novel therapies for serious inflammatory diseases like hidradenitis suppurativa (HS) and ulcerative colitis (UC).
Where is Azora Therapeutics based and how big is it?
Azora Therapeutics is based in Encino, California, United States. Fundz records about 3 employees.
Who are the decision-makers at Azora Therapeutics?
Fundz holds 1 contact at Azora Therapeutics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Azora Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • CYTRX CORP raised $8.2M on July 29, 2021.
  • Marani Health Inc raised $3.3M (Seed) on July 29, 2021.
  • Plantable Health Inc. raised $60K (Pre-Seed) on July 28, 2021.
  • HelloHero raised $5M on July 28, 2021.
  • NAVIGATE SURGICAL TECHNOLOGIES INC. raised $848K (Seed) on July 27, 2021.
  • Edwards Lifesciences raised $100K (Pre-Seed) on July 27, 2021.

Who to call at Azora Therapeutics, and when

A new round usually means Azora Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Azora Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Azora Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Azora Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Azora Therapeutics

Location

4267 Valley Meadow Road

Encino, California, United States

About

Azora is clinical stage pharmaceutical company developing novel therapies for serious inflammatory diseases like hidradenitis suppurativa (HS) and ulcerative colitis (UC).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Azora Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJulie S., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Azora Therapeutics's next move

See what Strategic adds

Azora Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.